Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

NMR vs IREN: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

NMR Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 10–0 Matrix Metrics)

NMR Overall Winner 6-Pillar Tally: NMR 6 – 0 IREN Matrix Metrics: NMR 10 – 0 IREN

As of Nov 17, 2026, Nomura Holdings, Inc (NMR) is the stronger overall head-to-head candidate over IREN Limited (IREN) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). NMR carries a Unified Composite Score of 44.5/100 (HOLD) at $9.34 (12.7x Forward P/E, 25.1% operating margin), whereas IREN carries 42.9/100 (HOLD) at $15.81 (65.4x Forward P/E, -72.9% operating margin).

  • Technical & Structure Timing Caution: NMR trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 45.5); meanwhile IREN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 29.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About NMR vs IREN
NMR NYSE Head-to-Head Winner
Nomura Holdings, Inc
Security Brokers, Dealers & Flotation Companies
$9.34
-1.74% 1D
Market Cap $28.3B
TTM Revenue $14.9B
Forward P/E 12.7x
Beta / 30D Vol 1.03β · 29% Vol
Unified Composite Score
44.5 / 100 HOLD
Tech 47.0 Fund 49.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 45
RSI-14: 45.5 · SMA20: $9.40 · SMA50: $9.68
IREN NASDAQ
IREN Limited Ordinary Shares
Finance Services
$15.81
-3.51% 1D
Market Cap $7.7B
TTM Revenue $695M
Forward P/E 65.4x
Beta / 30D Vol 3.88β · 136% Vol
Unified Composite Score
42.9 / 100 HOLD
Tech 25.0 Fund 44.0 Flow 57.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -18.8%), weak momentum, RSI 30
RSI-14: 29.5 · SMA20: $22.49 · SMA50: $32.86

6-Pillar Scorecard Institutional Category Breakdown (NMR 6 – 0 IREN)

Columns: Metric · NMR · IREN
1. Valuation Multiples NMR
Forward P/E 12.7x 65.4x
Trailing P/E 11.2x 65.4x
PEG Ratio 0.81x 4.05x
EV / Revenue 1.9x 20.7x
2. Growth & Scale NMR
Revenue Growth (YoY) +17.9% -5.0%
Earnings Growth (YoY) +13.6% +42.9%
TTM Revenue (USD) $14.9B $695M
Market Cap $28.3B $7.7B
3. Profitability & Quality NMR
Gross Margin 77.4% 73.4%
Operating Margin 25.1% -72.9%
Net Profit Margin 17.1% -194.3%
Return on Equity (ROE) 11.5% -33.8%
4. Balance Sheet & Cash Flow NMR
Cash Generation (TTM) N/A -$6.57B
Cash Flow Margin N/A N/A
Net Cash / Leverage $8.17 Book/Sh · 11.5% ROE $6.69B Net Debt (2.00x D/E)
Dividend Yield 3.34% None (0.00%)
5. Options & Positioning NMR
Options Structure Phase UNCLASSIFIED BREAKDOWN
Current IV / %ile 30.7% (<1st %ile) 129.7% (32nd %ile)
Put/Call OI Skew Thin ADR Chain 2.69x (Put-Skewed)
OBV Trend / Tech Phase NEUTRAL · Neutral DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat NMR
OpEx & R&D Intensity 52.3% of Rev ($7.77B) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Capital Markets Operator Capital Markets Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: NMR (10) vs IREN (0)
Institutional Metric NMR IREN Criterion Row Edge
Market Capitalization
Scale
$28.3B $7.7B Larger Scale NMR
Trailing P/E Ratio
Valuation
11.2x 65.4x Lower Multiple NMR
Forward P/E Ratio
Valuation
12.7x 65.4x Lower Multiple NMR
Revenue Growth (YoY)
Growth
+17.9% -5.0% Higher Growth NMR
Operating Margin (TTM)
Profitability
25.1% -72.9% Higher Margin NMR
Net Profit Margin
Profitability
17.1% -194.3% Higher Margin NMR
Return on Equity (ROE)
Capital Efficiency
11.5% -33.8% Higher ROE NMR
52-Week Range Position
Momentum
60% ($7–$11) 1% ($15–$71) Stronger Trend NMR
Beta / 30D Volatility
Risk Regime
1.03β · 29% Vol 3.88β · 136% Vol Lower Realized Risk NMR
Unified Institutional Score
Composite Signal
44.5 / 100 (HOLD) 42.9 / 100 (HOLD) Higher Composite NMR
Trailing 12M Revenue (USD)
Operating Scale
$14.9B $695M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
77.4% 73.4% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.81x PEG · 1.9x EV/Rev 4.05x PEG · 20.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($8.17 Book/Sh · 11.5% ROE) -$6.57B ($6.69B Net Debt (2.00x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon NMR +45.33 pp
NMR: +2.36% · IREN: -42.97%
3M Horizon NMR +61.24 pp
NMR: -1.84% · IREN: -63.08%
6M Horizon NMR +83.56 pp
NMR: +16.69% · IREN: -66.87%
1Y Horizon NMR +92.21 pp
NMR: +26.32% · IREN: -65.89%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NMR vs IREN. Trailing 12-month operating profitability (NMR 25.1% vs IREN -72.9%) and valuation multiples (NMR 12.7x vs IREN 65.4x Forward P/E) are benchmarked directly in Pillar 4 below.

NMR ADR TTM Benchmark FX-Normalized USD
TTM Revenue$14.9B
Gross Margin77.4%
Op. Margin25.1%
ROE / Fwd P/E11.5% · 12.7x
IREN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$695M
Gross Margin73.4%
Op. Margin-72.9%
ROE / Fwd P/E-33.8% · 65.4x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
NMR UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 30.7%
IV Percentile <1st %ile
Put/Call OI Skew Thin ADR Chain
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact NMR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
IREN BREAKDOWN
121d in phase · OBV DISTRIBUTION
Current IV 129.7%
IV Percentile 32nd %ile
Put/Call OI Skew 2.69x (Put-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact IREN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $16.39 · IV 122.1%

IREN Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($1,639)

Compare $1,639 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 122.1% ATM IV.

5-DAY BULLISH SWING Liq A

Dec 18 $17 / $20 Bull Call Spread

Buy 2x $17C · Sell 2x $20C · 32d

Net Entry $190 Debit
T+5d @ +5% Move +$28 (+15%)
Max Risk / Buffer $190 Capped
5d Edge & Liquidity 0.7x R:R · Liq A
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq A

Dec 18 $14 / $13 Bull Put Spread

Sell 4x $14P · Buy 4x $13P · 32d

Net Entry $140 Credit
Max Credit / Yield +$140 (+53.8% RoM)
Max Risk / Buffer -16.7% Cushion ($260 Mgn)
5d Edge & Liquidity 73% PoP · Liq A
Simulate 5-Day Payoff →
5-DAY DOWNSIDE SPREAD Liq A

Dec 18 $18 / $15 Bear Put Spread

Buy 1x $18P · Sell 1x $15P · 32d

Net Entry $159 Debit
T+5d @ -5% Drop +$17 (+11%)
Max Risk / Buffer $159 Capped
5d Edge & Liquidity 0.8x R:R · Liq A
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
NMR Moat Profile Scale & Operating Efficiency Moat
Capital Markets Operator
Competes within the Capital Markets value chain with $28.3B market capitalization and 25.1% operating margin.
OpEx & R&D Reinvestment 52.3% of Rev ($7.77B)
90D Engineering Disclosures 0 Published
IREN Moat Profile Cyclical / Execution-Driven Positioning
Capital Markets Operator
Competes within the Capital Markets value chain with $7.7B market capitalization and -72.9% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ NMR vs IREN Key Questions & Quantitative Answers

As of Nov 17, 2026, Nomura Holdings, Inc (NMR) is the stronger overall head-to-head candidate over IREN Limited (IREN) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). NMR carries a Unified Composite Score of 44.5/100 (HOLD) at $9.34 (12.7x Forward P/E, 25.1% operating margin), whereas IREN carries 42.9/100 (HOLD) at $15.81 (65.4x Forward P/E, -72.9% operating margin). Technical & Structure Timing Caution: NMR trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 45.5); meanwhile IREN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 29.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

NMR leads the Growth & Scale pillar: NMR posts +17.9% YoY revenue growth and +13.6% YoY earnings growth on $14.9B TTM revenue (77.4% gross margin, 25.1% operating margin), compared with IREN at -5.0% YoY revenue growth and +42.9% YoY earnings growth on $695M TTM revenue (73.4% gross margin, -72.9% operating margin). On trailing 12-month operating scale, NMR generates $14.9B in USD-normalized revenue versus $695M for IREN. In operating R&D and SG&A reinvestment, NMR deploys 52.3% of Rev ($7.77B) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for IREN.

NMR screens cheaper on headline valuation multiples. NMR trades at 12.7x Forward P/E, 11.2x Trailing P/E, 0.81x PEG, and 1.9x EV/Revenue (unreported cash flow margin), whereas IREN trades at 65.4x Forward P/E, 65.4x Trailing P/E, 4.05x PEG, and 20.7x EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against NMR (11.5% ROE) versus IREN (-33.8% ROE) capital efficiency.

In options market volatility and institutional positioning, NMR carries 30.7% implied volatility (<1st %ile, Compressed (<25th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.03β · 29% Vol realized risk). By comparison, IREN carries 129.7% implied volatility (32nd %ile, Balanced (25th–60th %ile)), a 2.69x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (3.88β · 136% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.